Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome
- PMID: 23068916
- PMCID: PMC4164649
- DOI: 10.1016/j.ajo.2012.07.019
Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome
Abstract
Purpose: To report the incidence and clinical outcomes of non-cytomegalovirus (non-CMV) ocular opportunistic infections in patients with acquired immunodeficiency syndrome (AIDS) in the era of highly active antiretroviral therapy.
Design: Multicenter, prospective, observational study of patients with AIDS.
Methods: Medical history, ophthalmologic examination, and laboratory tests were performed at enrollment and every 6 months subsequently. Once an ocular opportunistic infection was diagnosed, patients were seen every 3 months for outcomes.
Results: At enrollment, 37 non-CMV ocular opportunistic infections were diagnosed: 16 patients, herpetic retinitis; 11 patients, toxoplasmic retinitis; and 10 patients, choroiditis. During the follow-up period, the estimated incidences (and 95% confidence intervals [CI]) of these were: herpetic retinitis, 0.007/100 person-years (PY) (95% CI 0.0004, 0.039); toxoplasmic retinitis, 0.007/100 PY (95% CI 0.004, 0.039); and choroiditis, 0.014/ 100 PY (95% CI 0.0025, 0.050). The mortality rates appeared higher among those patients with newly diagnosed or incident herpetic retinitis and choroiditis (rates = 21.7 deaths/100 PY [P = .02] and 12.8 deaths/100 PY [P = .04]), respectively, than those for patients with AIDS without an ocular opportunistic infection (4.1 deaths/100 PY); toxoplasmic retinitis did not appear to be associated with greater mortality (6.4/100 PY, P = .47). Eyes with newly diagnosed herpetic retinitis appeared to have a poor visual prognosis, with high rates of visual impairment (37.9/100 PY) and blindness (17.5/100 PY), whereas those outcomes in eyes with choroiditis appeared to be lower (2.3/100 PY and 0/100 PY, respectively).
Conclusions: Although uncommon, non-CMV ocular opportunistic infections may be associated with high rates of visual loss and/or mortality.
Copyright © 2013 Elsevier Inc. All rights reserved.
References
-
- Jabs DA, Bartlett JG. AIDS and ophthalmology: a period of transition. Am J Ophthalmol. 1997 Aug;124(2):227–233. - PubMed
-
- Holtzer CD, Jacobson MA, Hadley WK, et al. Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994–1997. AIDS. 1998 Oct 1;12(14):1931–1933. - PubMed
-
- Thorne JE, Holbrook JT, Jabs DA, Kempen JH, Nichols C, Meinert CL for the Studies of Ocular Complications of AIDS Research Group. Effect of cytomegalovirus retinitis on the risk of visual acuity loss among patients with AIDS. Ophthalmology. 2007 Mar;114(3):591–598. - PubMed
-
- Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD for the Studies of the Ocular Complications of AIDS Research Group. The Longitudinal Study of the Ocular Complications of AIDS: 1. Ocular diagnoses at enrollment. Ophthalmology. 2007 Apr;114(4):780–786. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- ULI RR024996/RR/NCRR NIH HHS/United States
- 5M01 RR 05096/RR/NCRR NIH HHS/United States
- U01 AI 27660/AI/NIAID NIH HHS/United States
- U01 AI 27674/AI/NIAID NIH HHS/United States
- 5M01 RR 00865/RR/NCRR NIH HHS/United States
- U10 EY 08057/EY/NEI NIH HHS/United States
- P30 AI036211/AI/NIAID NIH HHS/United States
- 5M01 RR 00350/RR/NCRR NIH HHS/United States
- U10 EY008067/EY/NEI NIH HHS/United States
- U01 AI32783/AI/NIAID NIH HHS/United States
- U10 EY 08052/EY/NEI NIH HHS/United States
- U10 EY 08067/EY/NEI NIH HHS/United States
- 5M01 RR00043/RR/NCRR NIH HHS/United States
- U01 AI 27670/AI/NIAID NIH HHS/United States
- 5M01 RR00096/RR/NCRR NIH HHS/United States
- 5M01 RR00046/RR/NCRR NIH HHS/United States
- U01 AI25868/AI/NIAID NIH HHS/United States
- U01 AI 27663/AI/NIAID NIH HHS/United States
- P30 AI050410/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
